Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

Total market size is incorrect. Vyvanse alone just came off patent with $5B market. It will shrink fast with generic competition and maybe be half that within a year. Regardless, we are still in the billions. We have 10%+ of Adderall IR market, but doubt we will capture that much of rest of CNS space.

If we are first to file/launch for generic oxy, we will initially capture much more than 10% of the market temporarily. It was Interesting to hear Nasrat’s comments on opioids and the issues during last cc and yet an opioid is our next big filing we are waiting on from FDA. Is he having second thoughts? Perhaps they will sell it after approval similar to other opioids we used to own.